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SF-12® Health Survey (Version 1.0)
Title: SF-12® Health Survey (Version 1.0)
for use in Australia
(also known as the Short-Form 12-Item Health Survey).
Abbreviations: SF-12
Author(s) Name: John E. Ware, Jr.
Author(s) Address: QualityMetric Incorporated




Supplied by: QualityMetric Incorporated
640 George Washington Highway
Lincoln, RI 02865
USA
In Australia, SF-12® Health Survey manuals can be obtained from the:
Australian Health Outcomes Collaboration (AHOC)




Cost: An annual license fee applies for the use of the SF-12® Health Survey.
Survey users are required to register with QualityMetric Incorporated
and obtain a quote for the annual license fee that applies to their project.
The license charge will depend upon whether users require a commercial
or research license.
Register online at www.qualitymetric.com. Information on the SF group
of instruments can also be found at http://www.sf-36.com/
SF-12® manuals can be purchased in Australia from AHOC by
contacting Laura Willmott at willmott@uow.edu.au or by telephone on
02 4221-4411.
For technical questions about using the SF-12® Health Survey in
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Australia (including latest developments and research advice) contact Jan
Sansoni at jansan@netspeed.com.au or by telephone on 02 6291-7271
or 02 6205-0869.
Training requirements: Nil training is required for those professionals with qualifications and
experience in psychometrics and statistics. For those professionals
without these qualifications basic training is required in survey
administration and the characteristics of the SF-12® Health Survey. The
AHOC provides training workshops for the SF-12 and other
instruments.
Purpose: A shorter version of the SF-36® Health Survey designed to reproduce
the Physical Component Summary (PCS) and the Mental Component
Summary (MCS) scores.
Administration time: 2 minutes.
Instrument Type: Self-report Questionnaire.
Structure: The SF-12® Health Survey includes 12 questions from the SF-36®
Health Survey (Version 1). These include: 2 questions concerning
physical functioning; 2 questions on role limitations because of physical
health problems; 1 question on bodily pain; 1 question on general health
perceptions; 1 question on vitality (energy/fatigue); 1 question on social
functioning; 2 questions on role limitations because of emotional
problems; and 2 questions on general mental health (psychological
distress and psychological well-being).
Scoring: Scoring of individual items is identical to the SF-36® Health Survey.
Scoring algorithms are then applied to produce the PCS and MCS
scores.
Developed for: Those who need an even shorter generic measure of perceived health
status.
Normative Data: The SF-12® Health Survey was developed using normative data for the
SF-36® Health Survey in the United States.1 [See Ware, Kosinski &
Keller (1994)2 and Ware, Kosinski, Bayliss, McHorney, Rogers & Raczek
(1995)3] Wilson, Tucker & Chittleborough (2002)4 and Sanderson &
Andrews (2002)5 have conducted local equivalence studies and found
the SF-12 suitable for use in Australia.
Population health data using the SF-12 can be found in the 1997
Australian National Survey of Mental Health and Well-Being, the 2000
Mental Health Status of South Australian Population Study,6 the 2002
Longitudinal Investigation of Depression Outcomes (LIDO) Study7 and
the 2003 Australian Gulf War Veteran’s Health Study.8
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Clinical Data: A few clinical studies are listed below:
Arthritis: Gandhi, Salmon, Zhao, Lambert, Gore & Conrad (2001).9
Back Pain: Luo, Lynn George, Kakouras, Edwards, Pietrobon,
Richardson et al. (2003).10
Diabetes: Siddique, Ricci, Stewart, Sloan & Farup (2002).11
Elective Surgery: Derrett, Devlin, Hansen & Herbison (2003).12
Heart and Stroke Patients: Lim & Fisher (1999).13
Homeless Persons: Larson (2002).14
Myocardial Infarction: McBurney, Eagle, Kline-Rogers, Cooper, Mani,
Smith et al. (2002).15
Older Adults in a retirement community: Resnick & Nahm (2001).16
Retinal Diseases: Globe, Levin, Chang, Mackenzie & Azen (2002).17
Applications: In choosing between the SF-12® and the SF-36® Health Surveys users
should consider the trade-off between test taker burden (ie. number of
questions, time to complete) and the precision of scores (ie. how reliable
does the obtained score need to be). Ware et al. (1996)1 reports that
there is a 10% loss in the SF-12’s ability to distinguish between different
disease groups as compared to the SF-36 and that the SF-12 less
accurately reproduces the eight scale profile of the SF-36. Therefore it is
recommended that the SF-36 be used for smaller studies (less than n =
500). A recent paper by Rubenach, Shadbolt, McCallum & Nakamura
(2002)18 highlights this important distinction for clinical research studies.
Sanderson & Andrews5,19,20,21 have done considerable work in utilising
the SF-12 (MCS) as a disability measure for mental health disorders
(especially anxiety and depression). Salyers et al. (2000)22 have utilised
the SF-12 (MCS) for severe mental illness.
The SF-12 has been administered using interactive voice recognition
technology23 and in computerised format24 Telephone vs. mail-out
administration has also been compared.25
An acute (1 week) version of the SF-12® Health Survey is also available.
Like the SF-36® Health Survey, the SF-12® Health Survey has been
recently updated by QualityMetric Incorporated. The new version is
known as the SF-12v2TM Health Survey (Version 2). However, this
update of the SF-12 has yet to be field tested in Australia for equivalence
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or new norms developed for the Australian Population.











NA NA NA The important issue
here is how well the SF-
12 reproduces the PCS
and MCS scores of the
SF-36.






Adequate Test-Retest Reliability -
PCS = 0.89; MCS =
0.76.
Inter – rater NA NA NA The SF-12 is a self-
report measure.
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Yes Ware et al. (1996)1

























Good The SF-12 PCS and
MCS scores correlate
0.95 and 0.96 with
there SF-36
counterparts.





Good The criterion is how
well the SF-12
reproduces the PCS
and MCS scores of the
SF-36 (see above).
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Luo et al. (2001)10
Adequate
Cultural Applicability and Cultural Adaptations:
Jenkinson, Chandola, Coulter & Bruster (2001)37 in the United Kingdom
have made a useful contribution in this area. However, in Australia, little
research has been reported on the use of SF-12 with people from a non-
English speaking background and Aboriginal and Torres Strait Islanders.
Gender Appropriateness: Normative data is available for males and females.
Age Appropriateness: 14 years and over.
Summary: The SF-12® Health Survey is a suitable measure for large group
epidemiological studies (greater than n = 500) where information on the
SF-36® Health Survey Summary Scores (PCS + MCS) is required.
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